ISMRC 2025: Join ScreenCell to Discover Our CTC Detection Method

We are excited to announce that ScreenCell will be attending the upcoming edition of the International Symposium on Minimal Residual Cancer (ISMRC), which will take place over three days from May 7 to 9, 2025, in Nice, France.

Meet ScreenCell at ISMRC 2025

ISMRC
Source : Picture Gallery - ISMRC 2023
Device CYTO et MB - 2 dispositifs ScreenCell de détection des cellules tumorales circulantes

Come visit our booth at the next edition of ISMRC, where our team will introduce you to ScreenCell®, our simple and fast method for detecting and characterizing Circulating Tumor Cells (CTCs).

You will discover how our devices revolutionize the isolation and characterization of CTCs through:

  • A simplified workflow: Obtain actionable results in under 10 minutes.
 
  • Reduced research costs: Significantly lower your research project costs with our affordable, single-use devices.
 
  • High sample capacity: Process up to 50 patient samples per day.
 

We will also be there to unveil ScreenCell’s latest developments, discuss the promising results of our clinical studies, and talk about how artificial intelligence is being integrated into the analysis of circulating tumor cells.

Need more information about ScreenCell® technology?

Contact

Quentin DUBIEL

Communications and Webmarketing Officer
qdubiel@screencell.com

Share the article

Our latest news.

What Are Circulating Tumor Cells ?

Don't miss our news anymore.

Subscribe to our newsletter and receive the latest ScreenCell news directly by email.

Newsletter

Liquid biopsy for
enhancing patient care
through reliable CTC analysis

Webinar

Circulating Tumor Cell Analysis :
a new workflow combining ScreenCell® Technology
with Stilla Crystal Digital PCR®

Tuesday, April 8, 2025
04:00 PM CET
Wednesday, April 9, 2025
03:00 PM CST
Skip to content